References
- FazeliBRavariHMechanisms of thrombosis, available treatments and management challenges presented by thromboangiitis obliteransCurr Med Chem201522161992200125921644
- FazeliBRavariHAssadiRNatural history definition and a suggested clinical approach to Buerger’s disease: a case-control study with survival analysisVascular201220419820222375041
- FazeliBModagheghHRavraiHKazemzadehGThrombophlebitis migrans as a footprint of Buerger’s disease: a prospective-descriptive study in north-east of IranClin Rheumatol2008271555717554578
- FazeliBBuerger’s disease as an indicator of socioeconomic development in different societies, a cross-sectional descriptive study in the north-east of IranArch Med Sci20106334334722371769
- FazeliBRezaeeSAA review on thromboangiitis obliterans pathophysiology: thrombosis and angiitis, which is to blame?Vascular201119314115321652666
- IwaiTInoueYUmedaMOral bacteria in the occluded arteries of patients with Buerger diseaseJ Vasc Surg200542110711516012459
- ChenYWIwaiTUmedaMElevated IgG titers to periodontal pathogens related to Buerger diseaseInt J Cardiol20071221798117207873
- BartoloMAntignaniPLTodiniARRicciGBuerger’s disease: etiologic role of the rickettsiae?J Mal Vasc19871218284 French3559416
- BartoloMGuarnacciaGZardiOPossible rickettsial etiology of Buerger’s diseaseJ Mal Vasc198274309311 French6897655
- FazeliBRavariHGhazviniKRickettsia infection could be the missing piece of the Buerger’s disease puzzleInt Angiol201736541041626344511
- FazeliBRavariHFarzadniaMDoes a species of Rickettsia play a role in the pathophysiology of Buerger’s disease?Vascular201220633433621803838
- EmelyanovVVEvolutionary relationship of Rickettsiae and mitochondriaFEBS Lett20015011111811457448
- ParkBSLeeJORecognition of lipopolysaccharide pattern by TLR4 complexesExp Mol Med201345e6624310172
- NeyenCLemaitreBSensing Gram-negative bacteria: a phylogenetic perspectiveCurr Opin Immunol20163881726569344
- KangSSSimJRYunCHHanSHLipoteichoic acids as a major virulence factor causing inflammatory responses via Toll-like receptor 2Arch Pharm Res201639111519152927498542
- TedderTFCell-surface receptor shedding: a means of regulating functionAm J Respir Cell Mol Biol1991543053061654954
- ZagerRAJohnsonACLundSRandolph-HabeckerJToll-like receptor (TLR4) shedding and depletion: acute proximal tubular cell responses to hypoxic and toxic injuryAm J Physiol Renal Physiol20072921F304F31216885150
- NomuraFAkashiSSakaoYCutting edge: endotoxin tolerance in mouse peritoneal macrophages correlates with down-regulation of surface toll-like receptor 4 expressionJ Immunol200016473476347910725699
- MichalakŁBulskaMStrząbałaKSzcześniakPNeopterin as a marker of cellular immunological responsePostepy Hig Med Dosw2017711727736
- ShionoyaSDiagnostic criteria of Buerger’s diseaseInt J Cardiol199866Suppl 1S243S245 discussion S2479951826
- JooKParkWLimMJKwonSRYoonJSerum procalcitonin for differentiating bacterial infection from disease flares in patients with autoimmune diseasesJ Korean Med Sci20112691147115121935268
- SuhCHJeongYSParkHCRisk factors for infection and role of C-reactive protein in Korean patients with systemic lupus erythematosusClin Exp Rheumatol200119219119411326483
- SuhCHChunHYYeYMParkHSUnresponsiveness of C-reactive protein in the non-infectious inflammation of systemic lupus erythematosus is associated with interleukin 6Clin Immunol2006119329129616406714
- BuergerLThrombo-angiitis obliterans: a study of the vascular lesions leading to presenile spontaneous gangreneAm J Med Sci1908136567580
- MaddockWGCollerFAPeripheral vasoconstriction by tobacco and its relation to thrombo-angiitis obliteransAnn Surg1933981708117867010
- PowrieFCoffmanRLCytokine regulation of T-cell function: potential for therapeutic interventionTrends Pharmacol Sci19931451641688105593
- BanusSStengerRMGremmerERThe role of Toll-like receptor-4 in pertussis vaccine-induced immunityBMC Immunol2008912118498620
- FawzySMKhalifaRHExpression of TLR2 and TLR4 on CD14 monocytes in female SLE patients ERheumatology201663201
- MurrCWidnerBWirleitnerBFuchsDNeopterin as a marker for immune system activationCurr Drug Metab20023217518712003349
- MitakaCClinical laboratory differentiation of infectious versus noninfectious systemic inflammatory response syndromeClin Chim Acta20053511–2172915563869
- El-LebedyDHusseinJAshmawyIMohammedAMSerum level of neopterin is not a marker of disease activity in treated rheumatoid arthritis patientsClin Rheumatol20173691975197927699655
- NagyGBrózikMTornóciLGergelyPDiagnostic value of combined evaluation of neopterin and anti-DNA antibody levels for assessment of disease activity in systemic lupus erythematosusClin Exp Rheumatol200018669970511138331
- LatzEVisintinALienELipopolysaccharide rapidly traffics to and from the Golgi apparatus with the Toll-like receptor 4-MD-2-CD14 complex in a process that is distinct from the initiation of signal transductionJ Biol Chem200227749478344784312324469
- NomuraFAkashiSSakaoYCutting edge: endotoxin tolerance in mouse peritoneal macrophages correlates with down-regulation of surface Toll-like receptor 4 expressionJ Immunol200016473476347910725699
- GabayCKushnerIAcute-phase proteins and other systemic responses to inflammationN Engl J Med199934064484549971870